A Bilateral Dispensing Clinical Trial of Sapphire Lens Against Senofilcon A Lens Over 2 Weeks
- Conditions
- MyopiaHyperopia
- Interventions
- Device: SapphireDevice: senofilcon A
- Registration Number
- NCT02345811
- Lead Sponsor
- Coopervision, Inc.
- Brief Summary
To evaluate the clinical performance of an investigational silicone-hydrogel lens when worn on a daily wear modality over two weeks of lens wear.
- Detailed Description
This was a randomized, bilateral, 2 week cross over, double-masked, dispensing study comparing Sapphire test lens against the senofilcon A control lens. This study results were not used to support design validation of the test lens.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 34
- Is at least 17 years of age for Canada and 18 years of age for the USA and has full legal capacity to volunteer
- Has read and signed an information consent letter
- Is willing and able to follow instructions and maintain the appointment schedule;
- Is an adapted soft contact lens wearer
- Requires spectacle lens powers between -0.50 to -6.00 diopters sphere (0.25D steps) or +1.00 to +8.00 diopters sphere (1.00D steps)
- Has no more than 0.75 diopters of refractive astigmatism
- Willing to wear contact lens in both eyes
- Has manifest refraction visual acuities (VA) equal to or better than logMAR equivalent of 20/25 in each eye
- To be eligible for lens dispensing, the subject must have VA of logMAR equivalent of 20/30 or better in each eye with the study lenses and the investigator must judge the fit as acceptable
- Is participating in any concurrent clinical or research study
- Has any known active* ocular disease and/or infection
- Has a systemic condition that in the opinion of the investigator may affect a study outcome variable
- Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable
- Has known sensitivity to the diagnostic pharmaceuticals to be used in the study
- Is pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit)
- Is aphakic
- Has undergone refractive error surgery
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Sapphire Sapphire Participants were randomized to wear the Sapphire lens pair for two weeks during the cross over study. senofilcon A senofilcon A Participants were randomized to wear the senofilcon A lens pair for two weeks during the cross over study.
- Primary Outcome Measures
Name Time Method Subjective Rating for Comfort. 2-weeks - End of Day Subjective rating for comfort. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever
Vision Quality 2 weeks - End of Day Subjective rating for vision quality. Collected at dispense after settling of each study pair. (0-100 scale; 0=extremely poor vision, 100=excellent vision)
Surface Deposits 2-weeks Surface deposits is assessed. (Scale 0-4,0.25 steps) (0=no deposits; 1 = \<5 deposits; 2 = \>5 deposits or film 25-50% of surface; 3 = deposits 0.1 - 0.5mm or film 50-75% of surface; 4 = deposits \>0.5mm or film \> 75% of surface)
Lens Handling (Ease of Insertion) 2 weeks Lens handling - ease of insertion of the lenses. Scale 0-100, 0=could not place lens on eye, 100=always easy to place lens on eye.
Lens Handling (Ease of Removal) 2 weeks Lens handling - ease of removal of the lenses. Scale 0-100, 0=could not remove lens from eye, 100=always easy to remove lens from eye.
Subjective Preference for Comfort. 2 weeks Subjective rating for comfort. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever
Lens Surface Wettability 2 weeks Lens surface wettability assessed. Scale 0-4, 0.25 steps, 0=nonwetting, 4=excellent)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Center for Contact Lens Research, University of Waterloo
🇨🇦Waterloo, Ontario, Canada
Clinical Research Center, University of California, Berkeley
🇺🇸Berkeley, California, United States